Private Equity firm slams Prochlorperazine decision
Counsel to a private equity group fined by the UK antitrust watchdog for its alleged part in the Prochlorperazine cartel has hit out at the agency, telling the Competition Appeal Tribunal that the enforcer showed a “troubling lack of restraint” in its sanctions decision.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.